Daniil Gataulin
Stock Analyst at Chardan Capital
(0.99)
# 3,482
Out of 4,817 analysts
79
Total ratings
19.72%
Success rate
-10.09%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Daniil Gataulin
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ADVM Adverum Biotechnologies | Maintains: Buy | $40 → $33 | $2.72 | +1,113.24% | 6 | Apr 17, 2025 | |
| OCS Oculis Holding AG | Maintains: Buy | $28 | $18.11 | +54.61% | 6 | Apr 17, 2025 | |
| QURE uniQure | Maintains: Buy | $27 → $38 | $13.37 | +184.22% | 1 | Apr 1, 2025 | |
| FBRX Forte Biosciences | Maintains: Buy | $64 → $61 | $6.85 | +790.51% | 4 | Apr 1, 2025 | |
| CLSD Clearside Biomedical | Maintains: Buy | $6 | $0.80 | +650.00% | 4 | Mar 28, 2025 | |
| UBX Unity Biotechnology | Maintains: Buy | $6 → $4 | $0.92 | +334.74% | 3 | Mar 25, 2025 | |
| CGTX Cognition Therapeutics | Maintains: Buy | $11 → $8 | $0.36 | +2,100.22% | 6 | Mar 21, 2025 | |
| RGNX REGENXBIO | Maintains: Buy | $52 | $6.67 | +680.20% | 10 | Mar 20, 2025 | |
| CRVO CervoMed | Maintains: Buy | $14 | $9.38 | +49.25% | 5 | Mar 18, 2025 | |
| EYPT EyePoint Pharmaceuticals | Maintains: Buy | $33 | $5.90 | +459.32% | 10 | Mar 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $6 → $7 | $0.68 | +929.41% | 10 | Mar 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $36 | $5.66 | +536.04% | 3 | Feb 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $3 | $1.47 | +104.08% | 8 | Feb 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $220 | $2.84 | +7,646.48% | 1 | Mar 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $3.20 | - | 2 | Jul 25, 2023 |
Adverum Biotechnologies
Apr 17, 2025
Maintains: Buy
Price Target: $40 → $33
Current: $2.72
Upside: +1,113.24%
Oculis Holding AG
Apr 17, 2025
Maintains: Buy
Price Target: $28
Current: $18.11
Upside: +54.61%
uniQure
Apr 1, 2025
Maintains: Buy
Price Target: $27 → $38
Current: $13.37
Upside: +184.22%
Forte Biosciences
Apr 1, 2025
Maintains: Buy
Price Target: $64 → $61
Current: $6.85
Upside: +790.51%
Clearside Biomedical
Mar 28, 2025
Maintains: Buy
Price Target: $6
Current: $0.80
Upside: +650.00%
Unity Biotechnology
Mar 25, 2025
Maintains: Buy
Price Target: $6 → $4
Current: $0.92
Upside: +334.74%
Cognition Therapeutics
Mar 21, 2025
Maintains: Buy
Price Target: $11 → $8
Current: $0.36
Upside: +2,100.22%
REGENXBIO
Mar 20, 2025
Maintains: Buy
Price Target: $52
Current: $6.67
Upside: +680.20%
CervoMed
Mar 18, 2025
Maintains: Buy
Price Target: $14
Current: $9.38
Upside: +49.25%
EyePoint Pharmaceuticals
Mar 6, 2025
Maintains: Buy
Price Target: $33
Current: $5.90
Upside: +459.32%
Mar 6, 2025
Maintains: Buy
Price Target: $6 → $7
Current: $0.68
Upside: +929.41%
Feb 24, 2025
Maintains: Buy
Price Target: $36
Current: $5.66
Upside: +536.04%
Feb 18, 2025
Maintains: Neutral
Price Target: $3
Current: $1.47
Upside: +104.08%
Mar 7, 2024
Maintains: Buy
Price Target: $220
Current: $2.84
Upside: +7,646.48%
Jul 25, 2023
Downgrades: Neutral
Price Target: n/a
Current: $3.20
Upside: -